$IBB Recent Headlines 3 top trades for 2014 6:01 a.m.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$IBB Recent Headlines

3 top trades for 2014 6:01 a.m. Dec. 30, 2013 - Jeff Reeves
Glamour stocks show resilience in Fed wake 1:35 p.m. Dec. 26, 2013 - The Trading Deck
Look out below 5:39 p.m. Dec. 23, 2013 - Bill Donoghue
S&P 500 pulls in from less-charted territory 11:17 a.m. Dec. 11, 2013 - Michael Ashbaugh
Stay the course with caution 4:04 p.m. Dec. 2, 2013 - Bill Donoghue
This backdrop is what bull markets are made of 1:58 p.m. Dec. 2, 2013 - The Trading Deck
Nasdaq Composite rattles cage on the 4,000 mark 11:29 a.m. Nov. 25, 2013 - Michael Ashbaugh
From tiny Akorns grow mighty oaks? 10:03 a.m. Nov. 21, 2013 - The Trading Deck
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
ETFs to ride the market’s peaks 11:01 p.m. Nov. 3, 2013 - Jim Lowell
Top performers’ top November bets 11:01 p.m. Nov. 3, 2013 - Mark Hulbert
Don’t let taxes eat up your portfolio 4:31 p.m. Oct. 28, 2013 - Bill Donoghue
Healthcare stocks fall from first place in race for year's best-performing sector 2:32 p.m. Oct. 24, 2013 - blogs.marketwatch.com
Gold miners, biotech among worst-performing ETFs during shutdown 3:01 p.m. Oct. 15, 2013 - blogs.marketwatch.com
Here’s what happens when institutions blink 10:41 a.m. Oct. 11, 2013 - The Trading Deck
Biotech ETF's breakout: bullish for stocks overall? 12:11 p.m. Sept. 5, 2013 - blogs.marketwatch.com
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
S&P rises within view of major technical test 10:36 a.m. Sept. 5, 2013 - Michael Ashbaugh
Charting a market divergence 10:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Doug Kass gives you 3 or more reasons to short the market 10:50 a.m. Aug. 14, 2013 - blogs.marketwatch.com


GILD: Get on While Biotech Remains Hot 5:15 a.m. Jan. 3, 2014 - InvestorPlace.com
Why You Should Sell 3D Systems And Buy Organovo 4:20 p.m. Dec. 30, 2013 - Seeking Alpha
Market Not Overbought Despite Big Gains 8:43 p.m. Dec. 22, 2013 - InvestorPlace.com
Investigating Micro-Cap Medtech With Explosive Upside Potential: Brian Marckx 11:03 a.m. Dec. 21, 2013 - Seeking Alpha
'Fast Money' Recap: A Relief Rally 5:00 a.m. Dec. 19, 2013 - TheStreet.com
Arno Therapeutics: A Likely Acquisition For Opko 1:54 p.m. Dec. 17, 2013 - Seeking Alpha
The Race To Treat Stage III Melanoma Just Got A Lot More Interesting 1:46 p.m. Dec. 17, 2013 - Seeking Alpha
OPK – With Opko Health Hammered, Should You Run or Buy? 4:45 a.m. Dec. 17, 2013 - InvestorPlace.com
Why Northwest Biotherapeutics Is Different 3:21 p.m. Dec. 16, 2013 - Seeking Alpha
Understanding The Investment Opportunity In Developmental Biotechnology 6:31 p.m. Dec. 11, 2013 - Seeking Alpha
Gilead Sciences: Sovaldi Hepatitis C Pill Approved 6:25 p.m. Dec. 9, 2013 - Seeking Alpha
The 3 Best Sectors to Buy for 2014 4:59 a.m. Dec. 9, 2013 - InvestorPlace.com
Not Your Father's Diagnostics: Ram Selvaraju On How Molecular Genomics Invigorate The Sector 4:27 p.m. Dec. 6, 2013 - Seeking Alpha
Are Biotech ETFs Back on Track? - ETF News And Commentary 12:04 p.m. Dec. 4, 2013 - Zacks.com
Bear of the Day: SurModics (SRDX) - Bear of the Day 5:07 a.m. Dec. 4, 2013 - Zacks.com
Bear of the Day: SurModics (SRDX) - Bear of the Day 5:07 a.m. Dec. 4, 2013 - Zacks.com
2 Biotech Funds You Should Consider Owning For 2014 4:02 p.m. Dec. 3, 2013 - Seeking Alpha
The Big Pharma Stock Making Gains (and The One Suffering Big Losses) 11:54 a.m. Dec. 2, 2013 - TheStreet.com
Biotech Stocks With Promise 11:00 a.m. Nov. 29, 2013 - RealMoney.com
Life Sciences Offer Good Growth With Much Less Risk Than Biopharmaceuticals 11:54 a.m. Nov. 26, 2013 - Seeking Alpha


Regulus Announces Addition to NASDAQ Biotechnology Index 8:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 8:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 5:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 7:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 7:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 11:06 a.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 8:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 8:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 7:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 7:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 7:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 7:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 8:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 7:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 7:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 7:52 a.m. July 17, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTK, DNDN, IMGN and NVAX 7:43 a.m. July 17, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CELG, SIGA and SNTS 7:31 a.m. July 17, 2013 - ACCESSWIRE

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Indico Breach May Expose Thousands to Identity Theft

Updated Category News Views 4

Data Breach Unsettles Indico's Operations Well, this is the kind of headache nobody wants on their spreadsheet—the unpleasant fallout from a significant data breach is rocking Indico Data Solutions. When you hear words like 'unauthorized party' and 'exposed sensitive personal information,' it ought to make investors sit up and pay attention. On May 7, 2026, Indico, the...

Continue Reading
Zepp Health's Q2 2026 Results: Growth Amid Struggles

Updated Category News Views 4

Revenue Growth, Yet the Road Is Rocky Buckle up, investors, because Zepp Health Corporation's (NYSE: ZEPP) latest financials are a bit of a mixed salad—there's some good and some bad tossed in. Reporting a revenue of $63.5 million for the second quarter of 2026, the company managed to eke out a 6.9% increase year-over-year. But before you pop the champagne, let's dig a...

Continue Reading
Acer's New Monitors: ePaper, Triple Displays & More

Updated Category News Views 8

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

Continue Reading
BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Updated Category News Views 6

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

Continue Reading
Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

Updated Category News Views 0

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Continue Reading
Volato Group Faces Merger Scrutiny Amid SOAR Deal

Updated Category News Views 2

Unraveling the Volato Merger Drama Boy, the plot thickens with Volato Group, Inc. (SOAR), and it ain’t the first time we’ve seen this kind of shuffle in the market. Now, Volato’s got itself tangled up with Alignment Engine Inc. through a proposed merger. Sounds routine at first; we all know mergers are part of the corporate game. But here's the twist—shareholders...

Continue Reading
Kareem's Lebanese Kitchen: A Culinary Tribute to Maryland

Updated Category News Views 4

Embracing Tradition with a Modern Twist Well, here's to new beginnings wrapped in old flavors, folks. September 1, 2026, marks the arrival of Kareem's Lebanese Kitchen at Rio Lakefront in Gaithersburg, Maryland. It's where the Mediterranean meets the Chesapeake in an unexpected culinary celebration. Chef Rachid Eido's Legacy Third-generation Lebanese Chef Rachid Eido is...

Continue Reading
RealityMine Appoints CPO Amidst Strong Growth Momentum

Updated Category News Views 0

Pushing the Boundaries of Behavioral Data When a company like RealityMine posts a whopping 75% year-over-year revenue bump, you know they're not here to mess around. Enter Soumya Bijjal, a seasoned pro stepping in as their inaugural Chief Product Officer. This isn't just about adding to the C-suite boys' club; it's about locking in on a goldmine of behavioral data that's...

Continue Reading
Kroger's Strategic Shift: Ibbotson's Bold New Charge

Updated Category News Views 0

Kroger Welcomes a Seasoned Retail Veteran Change often arrives with the dawn of new leadership. As Kroger takes a page from the playbook of large-scale retail transformation, they've enlisted Mark Ibbotson. Effective September 14, Ibbotson will step in as Executive Vice President and Chief Store Operations Officer. It's a roll of the dice that could either accelerate...

Continue Reading
Innventure Faces Class Action Over Alleged Deception

Updated Category News Views 3

Unpacking the Innventure Debacle Innventure, Inc. (NASDAQ:INV) seems to have landed itself in hot water, and not the relaxing kind. The revelation that its grand AI data center project in Ontario might never have existed has stirred up quite a storm among shareholders. This isn't just some run-of-the-mill oversight. We're talking about allegations of concocted stories...

Continue Reading

Top 5 Most Recently Viewed Articles

ABN AMRO Advances Share Buyback Program with Key Updates

Updated Category News Views 207

ABN AMRO's Share Buyback Program Progress Overview ABN AMRO has recently reported significant advancements regarding its EUR 250 million share buyback program that was announced earlier in the month. This initiative aims to bolster shareholders' value and demonstrate the bank's commitment to enhancing its financial position. Transaction Details and Financial Insights...

Continue Reading
Exploring Recent Options Activity in Robinhood Markets Stock

Updated Category News Views 80

What Recent Options Trades Say About Robinhood Markets Investors are leaning bearish on Robinhood Markets, and the options tape shows it. Recent flow highlights how larger traders are setting up, offering a clear read on sentiment without guessing at motives. Breaking Down the Recent Trades In our review of options activity for Robinhood Markets (NASDAQ: HOOD), we counted...

Continue Reading
Neuronetics Enhances Registration Rights for Shareholders

Updated Category News Views 108

Neuronetics Amends Registration Rights Agreement Neuronetics, Inc. (NASDAQ: STIM), a pioneering medical technology firm, has recently made significant changes to its Registration Rights Agreement with Madryn Asset Management LP. This amendment extends the period for Madryn to demand the registration of their acquired shares, increasing the Demand Registration Period from...

Continue Reading
Macy's Sales Performance and Strategic Outlook for the Holidays

Updated Category News Views 168

Insights into Macy's Recent Performance Macy’s Inc (NYSE: M) has recently revealed its sales dynamics, indicating that even during a period of stronger financial results, its stock took a slight dip. Despite a notable improvement in sales, profit, and comparable growth metrics, the market response has been tempered, reflecting complex customer behaviors ahead of the...

Continue Reading
Steward Partners Celebrates Seven Teams in Forbes Rankings

Updated Category News Views 97

Celebrating Steward Partners' Remarkable Forbes Recognition Top honors reflect exceptional service, teamwork, and commitment to excellence Steward Partners, a thriving independent financial services firm known for its employee-owned model, recently celebrated a significant achievement. The firm proudly announced that seven of its partners have been recognized in the...

Continue Reading